Febbo William J's Form 4 filing
OptimizeRx Corp (OPRX) · filed Aug 23, 2022
- Accession no.
- 0001213900-22-050555
- Filed
- Aug 23, 2022
- Trade date
- Aug 19-22, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $251.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Febbo William JCIK 0001413987 | Director, Officer (CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2022 | Common Stock | PPurchaseAcquired | +5,400 | $16.18 | +$87,372 | 451,072 | Direct | |
| Aug 22, 2022 | Common Stock | PPurchaseAcquired | +10,700 | $15.29 | +$163,603 | 461,772 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.